The endothelial-mesenchymal transition (EndMT) of endothelial progenitor cells (EPCs) plays a notable role in pathological vascular remodeling. Emerging evidence indicated that long non-coding RNA-regulator of reprogramming (linc-ROR) can promote epithelial-mesenchymal transition (EMT) in a variety of cancer cells. Nevertheless, the function of linc-ROR in EPC EndMT has not been well elucidated. The present study investigated the effect and possible mechanisms of function of linc-ROR on the EndMT of EPCs. A linc-ROR overexpression lentiviral vector (LV linc-ROR) or a linc-ROR short hairpin RNA lentiviral vector (LV-shlinc-ROR) was used to up or downregulate linc-ROR expression in EPCs isolated from human umbilical cord blood. Functional experiments demonstrated that LV-linc-ROR promoted the proliferation and migration of EPCs, but inhibited EPC angiogenesis in vitro. In the meantime, reverse transcription-quantitative PCR and western blotting results showed that the expression of the endothelial cell markers vascular endothelial-cadherin and CD31 was decreased, while the expression of the mesenchymal cell markers ?-smooth muscle actin and SM22? was increased at both mRNA and protein levels in LV-linc-ROR-treated EPCs, indicating that linc-ROR induced EPC EndMT. Mechanistically, the dual-luciferase reporter assay demonstrated that microRNA (miR/miRNA)-145 was a direct target of linc-ROR, and miR-145 binds to the 3'-untranslated region of Smad3. Moreover, LV-shlinc-ROR increased the expression of miR-145, but decreased the expression of Smad3. In conclusion, linc-ROR promotes EPC EndMT, which may be associated with the miR-145/Smad3 signaling pathway. Keywords: Endothelial progenitor cells, Endothelial to mesenchymal transition, Linc-ROR, MiR-145, Atherosclerosis.

School of Basic Medical Sciences Shandong 2nd Medical University Weicheng Weifang Shandong China School of Basic Medical Sciences Shandong 2nd Medical University Weifang Shandong China

See more in PubMed

Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G, Baker AH. Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73:190–209. doi: 10.1016/j.jacc.2018.09.089. PubMed DOI PMC

Zhao X, Huang L, Yin Y, Fang Y, Zhou Y. Autologous endothelial progenitor cells transplantation promoting endothelial recovery in mice. Transpl Int. 2007;20:712–721. doi: 10.1111/j.1432-2277.2007.00497.x. PubMed DOI

Toya SP, Malik AB. Role of endothelial injury in disease mechanisms and contribution of progenitor cells in mediating endothelial repair. Immunobiology. 2012;217:569–580. doi: 10.1016/j.imbio.2011.03.006. PubMed DOI

Diez M, Musri MM, Ferrer E, Barbera JA, Peinado VI. Endothelial progenitor cells undergo an endothelial-to-mesenchymal transition-like process mediated by TGFbetaRI. Cardiovasc Res. 2010;88:502–511. doi: 10.1093/cvr/cvq236. PubMed DOI

Moonen JR, Krenning G, Brinker MG, Koerts JA, van Luyn MJ, Harmsen MC. Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny. Cardiovasc Res. 2010;86:506–515. doi: 10.1093/cvr/cvq012. PubMed DOI

Gao Y, Cui X, Wang M, Zhang Y, He Y, Li L, Li H, et al. Oscillatory shear stress induces the transition of EPCs into mesenchymal cells through ROS/PKCζ/p53 pathway. Life Sci. 2020;253:117728. doi: 10.1016/j.lfs.2020.117728. PubMed DOI

Alvarez-Dominguez JR, Hu W, Yuan B, Shi J, Park SS, Gromatzky AA, van Oudenaarden A, et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123:570–581. doi: 10.1182/blood-2013-10-530683. PubMed DOI PMC

Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159. doi: 10.1038/nrg2521. PubMed DOI

Loewer S, Cabili MN, Guttman M, Loh YH, Thomas K, Park IH, Garber M, et al. Large intergenic non-coding RNA-ROR modulates reprogramming of human induced pluripotent stem cells. Nat Genet. 2010;42:1113–1117. doi: 10.1038/ng.710. PubMed DOI PMC

Yi M, Wang S, Zhang X, Jiang L, Xia X, Zhang T, Fang X. Linc-ROR promotes EMT by targeting miR-204-5p/SMAD4 in endometriosis. Reprod Sci. 2023;30:2665–2679. doi: 10.1007/s43032-023-01204-0. PubMed DOI

Wen X, Wu Y, Lou Y, Xia Y, Yu X. The roles of Linc-ROR in the regulation of cancer stem cells. Transl Oncol. 2023;28:101602. doi: 10.1016/j.tranon.2022.101602. PubMed DOI PMC

Pan Y, Chen J, Tao L, Zhang K, Wang R, Chu X, Chen L. Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway. Oncotarget. 2017;8:33144–33158. doi: 10.18632/oncotarget.16562. PubMed DOI PMC

Wesseling M, Sakkers TR, De Jager S, Pasterkamp G, Goumans MJ. The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis. Vasc Pharmacol. 2018;106:1–8. doi: 10.1016/j.vph.2018.02.006. PubMed DOI

Qiu P, Feng XH, Li L. Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation. J Mol Cell Cardiol. 2003;35:1407–1420. doi: 10.1016/j.yjmcc.2003.09.002. PubMed DOI

Cho HJ, Yoo J. Rho activation is required for transforming growth factor-beta-induced epithelial-mesenchymal transition in lens epithelial cells. Cell Biol Int. 2007;31:1225–1230. doi: 10.1016/j.cellbi.2007.04.006. PubMed DOI

Li J, Qu X, Yao J, Caruana G, Ricardo SD, Yamamoto Y, Yamamoto H, et al. Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy. Diabetes. 2010;59:2612–2624. doi: 10.2337/db09-1631. PubMed DOI PMC

Gong F, Zhao F, Gan XD. Celastrol protects TGF-beta1-induced endothelial-mesenchymal transition. J Huazhong Univ Sci Technolog Med Sci. 2017;37:185–190. doi: 10.1007/s11596-017-1713-0. PubMed DOI

Li L, Wen J, Li H, He Y, Cui X, Zhang X, Guan X, et al. Exosomal circ-1199 derived from EPCs exposed to oscillating shear stress acts as a sponge of let-7g-5p to promote endothelial-mesenchymal transition of EPCs by increasing HMGA2 expression. Life Sci. 2023;312:121223. doi: 10.1016/j.lfs.2022.121223. PubMed DOI

Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288–293. doi: 10.1161/01.ATV.0000114236.77009.06. PubMed DOI

Sieveking DP, Buckle A, Celermajer DS, Ng MK. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol. 2008;51:660–668. doi: 10.1016/j.jacc.2007.09.059. PubMed DOI

Rostam-Alilou AA, Jarrah HR, Zolfagharian A, Bodaghi M. Fluid-structure interaction (FSI) simulation for studying the impact of atherosclerosis on hemodynamics, arterial tissue remodeling, and initiation risk of intracranial aneurysms. Biomech Model Mechan. 2022;21:1393–1406. doi: 10.1007/s10237-022-01597-y. PubMed DOI PMC

Alvandi Z, Nagata Y, Passos L, Hashemi GA, Guerrero JL, Wylie-Sears J, Romero DC, et al. Wnt site signaling inhibitor secreted frizzled-related protein 3 protects mitral valve endothelium from myocardial infarction-induced endothelial-to-mesenchymal transition. J Am Heart Assoc. 2022;11:e23695. doi: 10.1161/JAHA.121.023695. PubMed DOI PMC

Sabbineni H, Verma A, Artham S, Anderson D, Amaka O, Liu F, Narayanan SP, et al. Pharmacological inhibition of beta-catenin prevents EndMT in vitro and vascular remodeling in vivo resulting from endothelial Akt1 suppression. Biochem Pharmacol. 2019;164:205–215. doi: 10.1016/j.bcp.2019.04.016. PubMed DOI PMC

Hashimoto N, Phan SH, Imaizumi K, Matsuo M, Nakashima H, Kawabe T, Shimokata K, et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Resp Cell Mol. 2010;43:161–172. doi: 10.1165/rcmb.2009-0031OC. PubMed DOI PMC

Ma K, Li C, Xu J, Ren F, Xu X, Liu C, Niu B, et al. LncRNA Gm16410 regulates PM2.5-induced lung endothelial-mesenchymal transition via the TGF-β1/Smad3/p-Smad3 pathway. Ecotoxicol Environ Saf. 2020;205:111327. doi: 10.1016/j.ecoenv.2020.111327. PubMed DOI

Yin Q, He M, Huang L, Zhang X, Zhan J, Hu J. LncRNA ZFAS1 promotes ox-LDL induced EndMT through miR-150-5p/Notch3 signaling axis. Microvasc Res. 2021;134:104118. doi: 10.1016/j.mvr.2020.104118. PubMed DOI

Zhang R, Huang XQ, Jiang YY, Li N, Wang J, Chen SY. LncRNA TUG1 regulates autophagy-mediated endothelial-mesenchymal transition of liver sinusoidal endothelial cells by sponging miR-142-3p. Am J Transl Res. 2020;12:758–772. PubMed PMC

Ghafouri-Fard S, Pourtavakoli A, Hussen BM, Taheri M, Kiani A. A review on the importance of LINC-ROR in human disorders. Pathol Res Pract. 2023;244:154420. doi: 10.1016/j.prp.2023.154420. PubMed DOI

Ma X, Zhang H, Li Q, Schiferle E, Qin Y, Xiao S, Li T. FOXM1 promotes head and neck squamous cell carcinoma via activation of the Linc-ROR/LMO4/AKT/PI3K axis. Front Oncol. 2021;11:658712. doi: 10.3389/fonc.2021.658712. PubMed DOI PMC

Li J, Zhang S, Wu L, Pei M. Interaction between LncRNA-ROR and miR-145 contributes to epithelial-mesenchymal transition of ovarian cancer cells. Gen Physiol Biophys. 2019;38:461–471. doi: 10.4149/gpb_2019028. PubMed DOI

Ge H, Liu J, Liu F, Sun Y, Yang R. Long non-coding RNA ROR mitigates cobalt chloride-induced hypoxia injury through regulation of miR-145. Artif Cell Nanomed Bio. 2019;47:2221–2229. doi: 10.1080/21691401.2019.1620759. PubMed DOI

Hulshoff MS, Del MG, Kovacic J, Krenning G. Non-coding RNA in endothelial-to-mesenchymal transition. Cardiovasc Res. 2019;115:1716–1731. doi: 10.1093/cvr/cvz211. PubMed DOI PMC

Wang L, Tang R, Zhang Y, Chen S, Guo Y, Wang X, Liu Z, et al. PTH-induced EndMT via miR-29a-5p/GSAP/Notch1 pathway contributed to valvular calcification in rats with CKD. Cell Prolif. 2021;54:e13018. doi: 10.1111/cpr.13018. PubMed DOI PMC

Ding H, Yao J, Xie H, Wang C, Chen J, Wei K, Ji Y, et al. MicroRNA-195-5p downregulation inhibits endothelial mesenchymal transition and myocardial fibrosis in diabetic cardiomyopathy by targeting smad7 and inhibiting transforming growth factor beta1-smads-snail pathway. Front Physiol. 2021;12:709123. doi: 10.3389/fphys.2021.709123. PubMed DOI PMC

Zhang J, Zhang Z, Zhang DY, Zhu J, Zhang T, Wang C. MicroRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/AKT signalling pathway. PLoS One. 2013;8:e83294. doi: 10.1371/journal.pone.0083294. PubMed DOI PMC

Lei H, Gao Y, Xu X. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin. 2017;49:588–597. doi: 10.1093/abbs/gmx047. PubMed DOI

Hu H, Xu Z, Li C, Xu C, Lei Z, Zhang HT, Zhao J. Mir-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Lung Cancer. 2016;97:87–94. doi: 10.1016/j.lungcan.2016.04.017. PubMed DOI

Tian J, Zhang M, Suo M, Liu D, Wang X, Liu M, Pan J, et al. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats. J Cell Mol Med. 2021;25:7642–7659. doi: 10.1111/jcmm.16601. PubMed DOI PMC

Roberts AB, Tian F, Byfield SD, Stuelten C, Ooshima A, Saika S, Flanders KC. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 2006;17:19–27. doi: 10.1016/j.cytogfr.2005.09.008. PubMed DOI

Song S, Zhang R, Cao W, Fang G, Yu Y, Wan Y, Wang C, et al. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the snail promoter. J Cell Physiol. 2019;234:9052–9064. doi: 10.1002/jcp.27583. PubMed DOI PMC

Cooley BC, Nevado J, Mellad J, Yang D, St HC, Negro A, Fang F, et al. TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci Transl Med. 2014;6:227–234. doi: 10.1126/scitranslmed.3006927. PubMed DOI PMC